Platelet preservation during cardiopulmonary bypass with aprotinin.

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
C R WildevuurW van Oeveren

Abstract

A remarkable reduction of postoperative blood loss after cardiopulmonary bypass (CPB) has been achieved by prophylactic treatment with the proteinase inhibitor aprotinin. To reveal the mode of action of aprotinin, 23 CPB patients were randomised for aprotinin (2 x 10(6) KIU in the pump prime) or placebo treatment during CPB. Blood samples were collected before and during operation. Blood loss and blood requirements were 50% lower in the aprotinin treated patients than in the untreated patients. The adhesive capacity of platelets assessed by the amount of platelet membrane glycoprotein Ib (GP Ib) decreased by 50% in the untreated patients within 5 min of CPB and remained low during CPB, whereas GP Ib did not decrease in the aprotinin treated patients. Fibrinogen degradation products indicating plasmin activity could only be measured after 30 min of CPB in the untreated, but not in the aprotinin treated patients. The kallikrein inhibiting capacity was 34% decreased in the untreated patients within 5 min of CPB, while it increased by 84% and remained high during CPB in the aprotinin treated patients. Our results demonstrate that the improved haemostasis during and after CPB in patients treated with aprotinin can be attributed to t...Continue Reading

Citations

Apr 1, 1992·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J F Hardy, J Desroches
Nov 1, 1994·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·J F Hardy, S Bélisle
Jan 16, 2002·The Annals of Thoracic Surgery·R C LandisK M Taylor
Oct 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·D GreenM Moerch
May 10, 2001·European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery·M WilhelmiA Haverich
Jul 23, 1998·The New England Journal of Medicine·P M Mannucci
Nov 21, 2007·Surgery·Jerrold H Levy, Kenichi A Tanaka
Sep 1, 1999·Journal of Cardiothoracic and Vascular Anesthesia·H P WendelH M Hoffmeister
Aug 5, 2000·The Journal of Thoracic and Cardiovascular Surgery·M PoullisR C Landis
Jan 24, 2006·The Annals of Thoracic Surgery·Jonathan R S DayRobert C Landis
Nov 28, 2001·The Annals of Thoracic Surgery·R C LandisK M Taylor
Apr 4, 1998·The Annals of Thoracic Surgery·G CohenD A Mickle
Apr 1, 1993·The Annals of Thoracic Surgery·S Westaby
Mar 11, 2008·The Journal of Thoracic and Cardiovascular Surgery·Stephen Westaby
Apr 28, 2007·International Journal of Surgery·J R S Day, K M Taylor
Mar 1, 1993·The Annals of Thoracic Surgery·J BoldtG Hempelmann
Aug 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·R G SpeekenbrinkL Eijsman
Dec 1, 1995·The Journal of Thoracic and Cardiovascular Surgery·D J GoldsteinC R Smith
Jul 1, 1996·The Journal of Thoracic and Cardiovascular Surgery·E C ConstenM H van Oers
Dec 3, 1998·Scandinavian Cardiovascular Journal : SCJ·T IvertM Blombäck
Jan 30, 2007·Hematology/oncology Clinics of North America·R Clive Landis
Sep 9, 2006·Seminars in Cardiothoracic and Vascular Anesthesia·J R S DayK M Taylor
Jun 1, 1992·The British Journal of Surgery·R A LordJ L Francis
Sep 1, 1996·European Journal of Anaesthesiology·E MortierG Rolly
Nov 30, 1999·Anesthesia and Analgesia·C J O'ConnorK J Tuman
Sep 28, 2007·Anesthesia and Analgesia·Matthew D McEvoyFrancis G Spinale
Oct 24, 2002·Current Opinion in Hematology·Jason ChiuThomas J Reid
Dec 18, 1998·Anesthesiology·C Lentschener, D Benhamou

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.